Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study

NCT04707326 ACTIVE_NOT_RECRUITING Results posted

This study aims to determine real-life clinical efficacy of virally suppressed patienst switching to DTG/3TC compared to DTG triple drug cART controls

Details

Lead sponsor	Erasmus Medical Center
Status	ACTIVE_NOT_RECRUITING
Enrolment	2040
Start date	Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Nov 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hiv

Interventions

• Dolutegravir / Lamivudine Pill

Countries

Netherlands